Luxexcel
Develops a proprietary 3D printing technology for ophthalmic lenses, enabling direct printing of prescription lenses without polishing.
- CEO / Founder
- Fabio Esposito
- Team Size
- 11-50
- Stage
- Acquired
- Total Funding
- $36.8M
- Latest Round
- Acquired
- Key Investors
- Innovation Industries; SET Ventures; PMV; Munich Venture Partners; Chrysalix SET; KLA; Midtop Holding; Turnstone Capital Management
Technology & Products
Key Products
VisionPlatform; VisionEngine printer; VisionMaster software; VisionClear resin
Technological Advantage
Ability to embed active components like sensors and holographic films during the printing process; protected by Printoptical® Technology patents.
Differentiation
Value Proposition
Enables 'One-Step-Cad-to-Optic' printing of clear prescription lenses, reducing lead times and allowing integration of electronics, waveguides, and LCDs directly into the lens.
How They Differentiate
Pioneer and only company currently capable of 3D printing ophthalmic-grade prescription lenses at volume without post-print polishing.
Market & Competition
Target Customers
Ophthalmic labs and smart eyewear manufacturers
Industry Verticals
Eyewear; Medical; Consumer Electronics; Aerospace/Defense
Competitors
LuxCreo; Nanofabrica; Carbon
Growth & Milestones
Growth Metrics
Production grew from 5,000 lenses/year in 2018 to 50,000+ total by 2022; estimated revenue $6-6.7M.
Major Milestones
2009: World's first 3D printed functional glasses; 2017: First US lab installations; 2019: Reached 5,000 lenses/year production rate; 2022: Reached 50,000 lenses total production milestone; 2022: Acquired by Meta
Notable Customers
Meta